Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Achieve Life Sciences (ACHV) Change in Receivables (2016 - 2020)

Achieve Life Sciences (ACHV) has disclosed Change in Receivables for 10 consecutive years, with -$8000.0 as the latest value for Q1 2020.

  • Quarterly Change in Receivables changed N/A to -$8000.0 in Q1 2020 from the year-ago period, while the trailing twelve-month figure was -$26000.0 through Sep 2020, changed N/A year-over-year, with the annual reading at $1000.0 for FY2019, 150.0% up from the prior year.
  • Change in Receivables for Q1 2020 was -$8000.0 at Achieve Life Sciences, up from -$18000.0 in the prior quarter.
  • The five-year high for Change in Receivables was $401000.0 in Q3 2017, with the low at -$241000.0 in Q1 2017.
  • Average Change in Receivables over 4 years is $40181.8, with a median of -$5000.0 recorded in 2018.
  • The sharpest move saw Change in Receivables skyrocketed 31900.0% in 2016, then tumbled 210.05% in 2017.
  • Achieve Life Sciences' Change in Receivables stood at $320000.0 in 2016, then tumbled by 148.44% to -$155000.0 in 2017, then surged by 88.39% to -$18000.0 in 2018, then surged by 55.56% to -$8000.0 in 2020.
  • Per Business Quant, the three most recent readings for ACHV's Change in Receivables are -$8000.0 (Q1 2020), -$18000.0 (Q4 2018), and -$5000.0 (Q3 2018).